153 related articles for article (PubMed ID: 6846326)
1. Interaction of protamine sulfate with thrombin.
Cobel-Geard RJ; Hassouna HI
Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
[TBL] [Abstract][Full Text] [Related]
2. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
Brecher AS; Hellman K; Basista MH
Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
[TBL] [Abstract][Full Text] [Related]
3. Effect of protamine sulfate on antithrombin III activity.
Matsuo T; Shanberge JN; Matsuo O
Clin Chim Acta; 1983 Jul; 131(3):233-8. PubMed ID: 6883717
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant activity of a bacterial glycopeptide.
Akoum A; Josefonvicz J; Sigot M
Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
[TBL] [Abstract][Full Text] [Related]
5. Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation.
Podack ER; Dahlbäck B; Griffin JH
J Biol Chem; 1986 Jun; 261(16):7387-92. PubMed ID: 3754869
[TBL] [Abstract][Full Text] [Related]
6. Protamine inhibits formation of the covalent factor IXa-anti-thrombin complex.
Brecher AS; Roland AR
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):591-6. PubMed ID: 18685444
[TBL] [Abstract][Full Text] [Related]
7. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
Kitani T; Nagarajan SC; Shanberge JN
Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
[No Abstract] [Full Text] [Related]
8. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
9. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
10. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
Preissner KT; Delvos U; Müller-Berghaus G
Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
[TBL] [Abstract][Full Text] [Related]
11. Studies on the neutralizing mechanism of antithrombin activity of heparin by protamine.
Okajima Y; Kanayama S; Maeda Y; Urano S; Kitani T; Watada M; Nakagawa M; Ijichi H
Thromb Res; 1981 Oct 1-15; 24(1-2):21-9. PubMed ID: 7330836
[No Abstract] [Full Text] [Related]
12. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation.
Ni Ainle F; Preston RJ; Jenkins PV; Nel HJ; Johnson JA; Smith OP; White B; Fallon PG; O'Donnell JS
Blood; 2009 Aug; 114(8):1658-65. PubMed ID: 19531655
[TBL] [Abstract][Full Text] [Related]
13. The interactions between antithrombin III, thrombin and surface immobilized heparin.
van Delden CJ; Engbers GH; Feijen J
J Biomater Sci Polym Ed; 1996; 7(11):989-1004. PubMed ID: 8858487
[TBL] [Abstract][Full Text] [Related]
14. The effect of polycations on the inhibitory action of antithrombin III on thrombin in the absence and presence of polyanions.
Schiele U; Heuck CC
Thromb Res; 1986 Jul; 43(2):187-93. PubMed ID: 3738858
[TBL] [Abstract][Full Text] [Related]
15. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.
Liebman HA; Comenzo R; Allen ST; Dilorio JM
Am J Hematol; 1991 Sep; 38(1):24-9. PubMed ID: 1897511
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of heparin and LMW heparin on hemostasis.
Hirsh J; Buchanan MR
Thromb Res Suppl; 1991; 14():11-7. PubMed ID: 1658966
[TBL] [Abstract][Full Text] [Related]
17. Influence of platelet factor 4 on the neutralization of heparin by protamine.
Shanberge JN; Quattrociocchi-Longe TM
Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
[TBL] [Abstract][Full Text] [Related]
18. Endogenous anticoagulation during extracorporeal perfusion: generation of a heparinlike inhibitor.
Murphy TL; Walker FJ; Taylor FB; Beller-Todd B; Archer LT; Sofer SS; Hinshaw LB
Am J Physiol; 1980 Dec; 239(6):H742-50. PubMed ID: 7446747
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin-induced coagulation of plasma.
Bischof P; Meisser A; Haenggeli L; Reber G; Bouvier C; Béguin F; Herrmann WL; Sizonenko PC
Thromb Res; 1983 Oct; 32(1):45-55. PubMed ID: 6197764
[TBL] [Abstract][Full Text] [Related]
20. Prevention of thrombin/antithrombin III reaction in the presence of protamine or polybrene.
Oshima G
Thromb Res; 1988 Sep; 51(6):565-74. PubMed ID: 3187966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
